Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael Toubis
Observed names:
M TOUBIS,
M Toubis,
M. Toubis
Observed institutions:
National and Kapodistrian University of Athens,
Sismanoglio General Hospital,
Laiko General Hospital of Athens,
Sotiria General Hospital
OpenAlex ID:
A5113595520
Vinorelbine Plus Cisplatin Versus Docetaxel Plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Randomized Trial
2005
·
Vassilis Georgoulias
, Alexandros Ardavanis
, et al.
·
Journal of Clinical Oncology
·
160
PDF
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial
2010
·
G.P. Stathopoulos
, D. Antoniou
, et al.
·
Annals of Oncology
·
124
Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study
2004
·
V Georgoulias
, C Kouroussis
, et al.
·
British Journal of Cancer
·
56
PDF
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study
2001
·
S. Kakolyris
, E. Papadakis
, et al.
·
Lung Cancer
·
34
HLA Antigens and Otosclerosis: A Possible New Genetic Factor
1982
·
S. Gregoriadis
, J. Zervas
, et al.
·
Archives of Otolaryngology - Head and Neck Surgery
·
26
Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: A phase I-II trial
2007
·
George P. Stathopoulos
, John Dimitroulis
, et al.
·
Lung Cancer
·
14
HLA-A and B antigens and pulmonary tuberculosis in greeks
1987
·
J. Zervas
, C. Constantopoulos
, et al.
·
British Journal of Diseases of the Chest
·
11
HLA antigens and congenital dislocation of the hip
1983
·
J ZERVAS
, H ZOUBOPOULOS
, et al.
·
Tissue Antigens
·
6
A phase II study of docetaxel (D) and gemcitabine (G) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)
1999
·
S. Agelaki
, E. Papadakis
, et al.
·
European Journal of Cancer
·
5
Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study.
2006
·
J Dimitroulis
, M Toubis
, et al.
·
PubMed
·
4
Paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as first line treatment in small cell lung cancer (SCLC): a preliminary analysis of a multicenter randomized phase III trial
1999
·
D. Mavroudis
, E. Papadakis
, et al.
·
European Journal of Cancer
·
4
HLA antigens in diabetics with calcified shoulder periarthritis (CSP).
1986
·
J Zervas
, M Mavrikakis
, et al.
·
PubMed
·
2
Hla Typing in the Hong Kong Chest Service/British Medical Research Council Study of Factors Associated with the Breakdown to Active Tuberculosis of Inactive Pulmonary Lesions
1989
·
J. Zervas
, K. Konstantopoulos
, et al.
·
American Review of Respiratory Disease
·
1
6599 POSTER Comparison of cisplatin–paclitaxel combination versus cisplatinetoposide as first line chemotherapy in SCLC
2007
·
G. Stathopoulos
, J. Dimitroulis
, et al.
·
European Journal of Cancer Supplements
Alternative administration of paclitaxel-gemcitabine and paclitaxel-vinorelbine as first line treatment in NSCLC patients. A phase II study
2005
·
J. Dimitroulis
, M. Toubis
, et al.
·
Journal of Clinical Oncology
The sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study
2001
·
D. Mavroudis
, S. Agelaki
, et al.
·
European Journal of Cancer
Disturbances of Calcium Metabolism During Rifampicin Therapy
1978
·
A. Simos
, V. Cotsovoulou
, et al.
·
Elsevier eBooks
Show more works
View as search
Works count:
18
Citation count:
447
H-index:
7
I10-index:
7
Year
Topic
Type
